FWS-HQ-IA-2026-0496
Federal Regulations
How Congress's laws become real-world rules. Browse regulatory dockets from Regulations.gov — tracking rulemaking activity, public comment periods, and the agencies turning legislation into policy.
Dockets
3,463
Showing 30 of 3,463 dockets
Nonrulemaking
FWS
Open for Comments
2 docsNo comments
Comments due May 12, 2026
Nonrulemaking
FDA
FDA-2026-H-0292
DAB Civil Money Penalty; Bradley P. Edwards and Charles Edwards Jr. d/b/a Edwards Grocery; CLOSED 04/10/2026
1 docNo comments
Nonrulemaking
FDA
FDA-2026-H-2291
DAB Civil Money Penalty; MK Stores LLC, d/b/a Marathon / Snak Atak 33; CLOSED 04/10/2026
1 docNo comments
Nonrulemaking
FDA
FDA-2026-H-3156
DAB Civil Money Penalty; T & B Enterprises of Rockland, Inc. d/b/a T & B's Grocery & Restaurant; CLOSED 04/10/2026
1 docNo comments
Nonrulemaking
FDA
FDA-2026-H-2907
DAB Civil Money Penalty; Marywhite Enterprises Inc. d/b/a Marathon; CLOSED 04/10/2026
1 docNo comments
Nonrulemaking
FDA
1 docNo comments
Nonrulemaking
FDA
FDA-2026-H-2609
DAB Civil Money Penalty; Family Dollar Stores of New Jersey, LLC d/b/a Family Dollar 6965; CLOSED 04/10/2026
1 docNo comments
Nonrulemaking
FDA
FDA-1995-N-0225
Topical Antimicrobial Drug Products for OTC Human Use
9 docs1 comment
Nonrulemaking
USDA
2 docs244 comments
Nonrulemaking
FDA
FDA-1995-P-0035
Use URAA to Determine Approval eff date of ANDA's
2 docs9 comments
Nonrulemaking
BOEM
1 doc933 comments
Nonrulemaking
FDA
FDA-1995-P-0024
Refuse to Approve Any NDA for RU 486 Used as Abortifacient
1 docNo comments
Nonrulemaking
FDA
Open for Comments
39 docs16 comments
Comments due Mar 23, 2018
Nonrulemaking
FDA
FDA-2026-E-3826
Patent Term Extension Application for VOYXACT® (sibeprenlimab-szsi), Patent No. 10,385,123
2 docsNo comments
Nonrulemaking
NRC
Open for Comments
2 docs1 comment
Comments due Apr 29, 2026
Rulemaking
NRC
Open for Comments
1 doc5 comments
Comments due Apr 14, 2026
Nonrulemaking
FDA
15 docsNo comments
Nonrulemaking
FDA
1 docNo comments
Nonrulemaking
FDA
1 docNo comments
Nonrulemaking
OPM
OPM-2026-0101
E-Filing PRA & SORN
1 doc1 comment
Rulemaking
BOEM
Open for Comments
3 docs3 comments
Comments due May 9, 2026
Rulemaking
OCC
Open for Comments
OCC-2026-0034
Regulatory Capital Rules: Regulatory Capital and Standardized Approach for Risk-weighted Assets
1 doc22 comments
Comments due Jun 19, 2026
Rulemaking
EOIR
2 docs919 comments
Nonrulemaking
ONRR
Open for Comments
10 docs1 comment
Comments due Jun 9, 2026
Nonrulemaking
FDA
Open for Comments
1 doc1 comment
Comments due Apr 28, 2026
Nonrulemaking
FDA
FDA-2026-E-3828
Patent Term Extension Application for YARTEMLEA® (narsoplimab-wuug), Patent No. 9,011,860
2 docsNo comments
Nonrulemaking
FDA
FDA-2026-E-3824
Patent Term Extension Application for NUZOLVENCE® (zoliflodacin), Patent No. 9,187,495
2 docsNo comments
Nonrulemaking
FDA
2 docsNo comments
Nonrulemaking
FDA
2 docsNo comments
Nonrulemaking
FDA
2 docsNo comments